Clinical Trial Update: Time to Protection and Adherence Requirements of Raltegravir With or Without Lamivudine in Protection From HIV Infection [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating time to protection and adherence requirements of raltegravir with or without lamivudine for HIV infection prevention. Completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lamivudine (lamivudine)
• Raltegravir (raltegravir)

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Hiv | Phase 4 | Status: COMPLETED | Results posted: 2021-02-21